August 9, 2012
Pennsylvania-based Mylan Inc. said a subsidiary has launched commercial operations in India, beginning with HIV/AIDS drugs. After initially offering 18 antiretrovirals, Mylan Pharmaceuticals Private Ltd. plans to add therapeutic categories and enlarge its sales force. Mylan already is active in the nation, having acquired a majority stake in Matrix Laboratories of India in 2007 and bought the remainder of the company in 2009. India is home to the world's third-largest population of HIV/AIDS patients, according to the National AIDS Control Organization.